Table 2.
Antimicrobial agent | MIC data (μg/ml) |
% resistant | ||
---|---|---|---|---|
Range | MIC50 | MIC90 | ||
Chlorhexidine | 0.5–4 | 2 | 4 | NAa |
Clindamycin | ≤0.12 to >16 | >16 | >16 | 55 |
Erythromycin | ≤0.25 to >32 | >32 | >32 | 90 |
Tetracycline | ≤0.5 to >64 | ≤0.5 | ≤0.5 | 4 |
Trimethoprim-sulfamethoxazole | ≤0.25 to >32 | ≤0.25 | ≤0.25 | 2 |
Gentamicin | ≤0.5 to >64 | ≤0.5 | 64 | 12 |
Levofloxacin | ≤0.25 to >32 | 32 | >32 | 98 |
Vancomycin | 0.5–2 | 1 | 1 | 0 |
Daptomycin | ≤0.5–4 | ≤0.5 | ≤0.5 | NA |
Quinupristin-dalfopristin | ≤0.5–4 | ≤0.5 | ≤0.5 | <1 |
Linezolid | ≤1–8 | 2 | 2 | <1 |
Rifampin | ≤0.5 to >4 | ≤0.5 | ≤0.5 | 1 |
Mupirocinb | ||||
Low-level resistance isolates | 3 | |||
High-level resistance isolates | 9 |
NA, not available, because the Clinical and Laboratory Standards Institute has not yet established breakpoints for resistance to this agent.
Disk diffusion testing was performed, and so no MICs are reported here.